top of page
HOME
ABOUT US
BOARD
MANAGEMENT
LICENSING
GOVERNANCE
CEO's LETTER
ORIGIN
INVESTORS
SERVICES
SUPPLY CHAIN
MANUFACTURING
INNOVATION
PARTNERSHIPS
MEDICAL ADVISORY
BRAND STRATEGY
ACCESS
FIND A DOCTOR
QLD
NSW
VIC
WA
CLINICAL RESEARCH
CLINICAL TRIAL
NEWS
CONTACT
More
Use tab to navigate through the menu items.
Search
Dec 8, 2023
Cannabis Pill Trial
Dec 8, 2023
Australia Pioneers World’s First CBD Pill for Chronic Pain Relief in Groundbreaking Trial
Dec 8, 2023
Promethean BioPharma joins over-the-counter CBD race
Dec 8, 2023
Over-the-counter cannabis pain relief on the horizon
Oct 4, 2021
Therapeutic Goods Administration relaxes the requirements on nicotine as an unregistered medicine
Sep 18, 2021
Novel psychedelic medicines are the next global health revolution
Aug 10, 2021
Sale of TCann to Promethean
Jul 5, 2021
Promethean BioPharma supports the rescheduling of psilocybin and MDMA in Australia
Jan 7, 2021
The Third Promethean Moment
Announcements
bottom of page
